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Summary
 
The development of B lymphocytes from progenitor cells is dependent on the expression of a
pre–B cell–specific receptor made up by a 
 
m
 
 heavy chain associated with the surrogate light
chains, immunoglobulin (Ig)
 
a
 
, and Ig
 
b
 
. A variant pre–B cell receptor can be formed in which
the 
 
m
 
 heavy chain is exchanged for a truncated 
 
m
 
 chain denoted D
 
m
 
. To investigate the role of
this receptor in the development of B cells, we have generated transgenic mice that express the
D
 
m
 
 protein in cells of the B lineage. Analysis of these mice reveal that D
 
m
 
 expression leads to a
partial block in B cell development at the early pre–B cell stage, probably by inhibiting V
 
H
 
 to
D
 
H
 
J
 
H
 
 rearrangement. Furthermore, we provide evidence that D
 
m
 
 induces V
 
L
 
 to J
 
L
 
 rearrange-
ments.
 
D
 
uring B cell differentiation, the genes encoding the
heavy and light chains of the immunoglobulin mole-
cules are assembled from germline gene segments in an or-
dered fashion (1, 2). Initially, a D
 
H
 
 segment is joined to a J
 
H
 
segment in the heavy chain locus on both chromosomes.
Subsequently, a V
 
H
 
 gene segment is rearranged to the D
 
H
 
J
 
H
 
complex. If this renders a functional rearrangement, a 
 
m
 
heavy chain is expressed on the cell surface, together with
the surrogate light chains encoded by the genes 
 
l
 
5 and
Vpre-B (3–5). This complex, denoted the pre–B cell re-
ceptor (pBCR),
 
1
 
 has been shown to be of vital importance
for maturation of B lymphocytes. Thus, in mice deficient
in this receptor, B cell differentiation is arrested at an early
stage (6–9). Moreover, the pBCR gives a signal to the cell
to stop further rearrangements on the heavy chain locus
(10–13) and to upregulate rearrangement of the light chain
gene segments (14, 15). Due to an inexact joining mecha-
nism, the D
 
H
 
 can be rearranged to the J
 
H
 
 in three possible
reading frames (RFs). A majority of the D
 
H
 
 segments carry
their own promoter and an ATG translational initiation
codon. When the D
 
H
 
 is rearranged to a J
 
H
 
 in RF2, accord-
ing to the nomenclature of Ichihara et al. (16), this D
 
H
 
J
 
H
 
complex can be translated into a truncated 
 
m
 
 chain, de-
noted D
 
m
 
 (17). A well-documented underrepresentation of
RF2 in V
 
H
 
D
 
H
 
J
 
H
 
 as well as D
 
H
 
J
 
H
 
 joints (18–20) has been
suggested to be mediated by this protein expressed on the
cell surface (19). The mechanism by which this occurs is,
however, unknown. It has been postulated that the D
 
m
 
protein in association with the surrogate light chains (D
 
m
 
pBCR) possess signalling properties similar to those given
by the pBCR, including signals mediating allelic exclusion
(21–24). If so, cells expressing the D
 
m
 
 protein on the cell
surface would be arrested at an early developmental stage
due to the absence of a complete 
 
m
 
 heavy chain.
To investigate the effect of D
 
m
 
 expression on B cell dif-
ferentiation, we generated mice transgenic for the D
 
m
 
 pro-
tein under control of its endogenous promoter (D
 
m
 
-endo)
or, alternatively, under control of the pre–B cell and B cell–
specific mb-1 promoter (D
 
m
 
–mb-1; references 25–27).
 
Materials and Methods
 
Transgenic Constructs.
 
The D
 
m
 
 transgenic constructs were
created by PCR amplification of D
 
H
 
J
 
H
 
 rearrangements, using
DNA from large pre–B cells as template. The primers (Fig. 1 
 
A
 
, 
 
a
 
and 
 
b
 
) hybridize to sequences 0.42 kb 5
 
9
 
 of the D
 
H
 
 segment and
0.62 kb 3
 
9
 
 of J
 
H
 
4, respectively. The PCR products were se-
quenced, and a fragment consisting of DFL16.1 joined to J
 
H
 
4 in
RF2 was cut with NotI and EcoRI, and cloned into pBluescript.
A second construct in which the endogenous promoter was re-
placed with the mb-1 promoter, was generated by PCR amplifi-
cation using primers c and b (Fig. 1 
 
A
 
), and the fragment was cut
with BamHI/EcoRI and cloned into pBluescript containing the
mb-1 promoter. The 0.3-kb fragment containing the mb-1 pro-
moter was isolated by PCR according to the published sequence
(27). Next, the plasmids were cut with Xba1 and Xho1, and li-
gated with a 9.8-kb XbaI–XhoI fragment from the plasmid p21-
H22 (10), provided by Dr. T. Leandersson (University of Lund,
Lund, Sweden), containing the complete membrane heavy chain
 
1
 
Abbreviations used in this paper:
 
 HSA, heat stable antigen; pBCR, pre–B
cell receptor; RF, reading frame.
 
I. Bergqvist and U.-C. Tornberg contributed equally to this work.
  
704
 
Regulation of B Lymphocyte Development
constant region. The plasmids containing the final constructs
were digested with NotI and XhoI, the inserts were gel purified
and injected into fertilized oocytes of F1(C57BL/6 
 
3
 
 CBA)
mice. The injected zygotes were transplanted into oviducts of
pseudopregnant female mice. Tail DNA from offspring was di-
gested with BamHI, and a 0.3-kb probe comprising the C
 
m
 
1
exon was used for Southern blot, detecting a band of 6.2/6.5 kb
in transgenic mice (Fig. 1 
 
B
 
).
 
PCR Amplifications and Southern Blot Analysis.
 
PCR amplifica-
tions performed to isolate the gene fragments used for the trans-
genic vectors were carried out over 30 cycles (1 min at 95
 
8
 
C, 1 min
at 55
 
8
 
C, and 2 min at 72
 
8
 
C) in a programmable thermal controller
(PTC-100; MJ Research Inc., Watertown, MA), using Dy-
naZyme II DNA polymerase (Finnzymes Oy, Espoo, Finland) with
the supplied buffer. The following primers were used for PCR
amplification: (
 
a
 
) 5
 
9
 
-CGCGCGGCCGCTCAAAGCACAATGC-
CTGG-3
 
9
 
, (
 
b
 
) 5
 
9
 
-GGAATTCCTTCTAATATTCCATACAC-
ATA-3
 
9
 
, and (
 
c
 
) 5
 
9
 
-AAGGATCCATGACAACTGAAACTCA-
ACC-3
 
9
 
.
Quantification of IgH chain rearrangements were performed
according to Costa et al. (28). In brief, DNA was prepared by lys-
ing 4–16 
 
3
 
 10
 
4
 
 CD43
 
1
 
, B220
 
1
 
, IgM
 
2
 
 cells in 200 
 
m
 
l lysis buffer
(50 mM Tris-HCl, pH 8.0, 100 mM EDTA, 100 mM NaCl, 1%
SDS, and 60 
 
m
 
g/ml proteinase K), incubating them at 55
 
8
 
C for 2 h,
and then precipitating the DNA with isopropanol. The DNA was
dissolved in water, and used for PCR at a concentration of 
 
z
 
5–20
ng/reaction. PCR amplifications were carried out for 30 cycles
(30 s at 95
 
8
 
C, 2 min at 55
 
8
 
C, and 1 min and 45 s at 72
 
8
 
C) in a
programmable thermal controller (PTC-100; MJ Research Inc.),
using DynaZyme II DNA polymerase (Finnzymes Oy) with the
supplied buffer. Limited PCR amplification of a nonrearranging
locus (
 
l
 
5) was used to normalize the DNA content in the reac-
tions. The following primers, at a concentration of 100 ng/reaction,
were used for PCR amplification: JH: 5
 
9
 
-GGCTCCCAAT-
GACCCTTTCTG, DH: 5
 
9
 
-GTCAAGGGATCTACTACTGTG,
VJ558: 5
 
9
 
-TCCTCCAGCACAGCCTACATG, 5
 
9l
 
5: 5
 
9
 
-CAA-
GTCTGACCCCTTGGTCACTC, 3
 
9l
 
5: 5
 
9
 
-TGTGAGGCAT-
CCACTGGTCAGATA. One-tenth of the 50 
 
m
 
l PCR reaction
was run on a 1.7% agarose gel, blotted onto Zeta-Probe GT blot-
ting membranes (BioRad, Hercules, CA) and hybridized with a
510-bp probe spanning the JH1 and JH2 exons (for detection of
D
 
H
 
J
 
H
 
 and V
 
H
 
D
 
H
 
J
 
H
 
 rearrangements) or a 690-bp probe (29; pro-
vided by Dr. L. Mårtensson, University of Lund, Lund, Sweden)
for detection of 
 
l
 
5. Intensity of the bands was determined using a
Phosphor Imager (Molecular Dynamics, Sunnyvale, CA).
 
Northern Blot Analysis.
 
Total RNA from spleen and BM was
Figure 1. (A) Schematic out-
line of the transgenic constructs
used. The Dm-endo construct
included a 0.3-kb fragment con-
taining the endogenous pro-
moter (open box), a DFLJH4 re-
arrangement in RF2, the IgH
enhancer (E), and the complete
Cm sequence. Arrowheads, the lo-
cation of PCR primers used to
generate the constructs. The
probe used for Southern blot
analysis is depicted in the figure
together with the size of the
BamHI fragment detected in
transgenic mice (6.5 kb). The
construct used to create Dm–
mb-1 transgenic mice was de-
rived from the Dm-endo con-
struct by replacing the region
upstream of the ATG with a 0.3-
kb fragment containing the mb-1
promoter (shaded box). B,
BamHI; N, NotI; R, EcoRI; Xb,
XbaI;  Xh, XhoI. (B) Southern
blot analysis of genomic tail
DNA digested with BamHI and
hybridized with Cm exon 1 as a
probe. The 6.5-kb Dm transgenic band and the z10-kb band representing the endogenous Cm locus are indicated. Lane 1, C57/BL6; lane 2, Dm-endo,
founder 13; lane 3, Dm–mb-1, founder 23. The transgenic band in lane 3 is 0.3 kb shorter than in lane 2, due to the insertion of a BamHI site 39of the
mb1 promoter in the construct. (C) Northern blot analysis of total RNA from bone marrow and spleen cells hybridized with a probe complementary to
the DHJH joint used in the constructs. Blots from transgenic (tg) mice and littermate controls (lm) are shown. Lanes 1, 2, 5, and 6: Dm–mb-1 line 26.
Lanes 3, 4, 7, and 8: Dm-endo line 11. The 1.9-kb Dm transcript and the 18 S ribosomal RNA are indicated in the figure. GAPDH was used as a control
for quantification. (D) Expression of the Dm protein in transgenic mice. Proteins extracted from bone marrow or spleen cells were analyzed by Western
blot. A band of z69 kD was detected in transgenic mice using an anti-IgM antibody. Blots representing transgenic (tg) mice and littermate controls (lm)
are shown. Dm–mb-1, lanes 1, 2, 5, and 6; Dm-endo, lanes 3, 4, 7, and 8. (E) VHDHJH and DHJH rearrangements in Dm-endo transgenic mice.
B2201CD431 pre–B cells were isolated by cell sorting from transgenic mice (tg) and from littermate controls (lm). Semiquantitative PCR (28) was per-
formed using a primer hybridizing to a sequence downstream of JH2, together with primers complementary to either recombination sequences 59of all D
regions or to members of the J558 family. As the target sequence for the JH primer is not included in the transgenic construct, there is no amplification
of the transgene itself. Limited PCR amplification of a nonrearranging locus (l5) was used to normalize the DNA content in the reactions. PCR prod-
ucts were hybridized with a probe complementary to the JH1 and JH2 exons, or to the l5 gene. The upper and lower panels show rearrangements to the
JH1 and the JH2 gene segments, respectively.705 Tornberg et al.
isolated using Ultraspec RNA isolation system (Biotecx, Hous-
ton, TX). The RNA was electrophoresed in a 1.2% agarose/
formaldehyde gel, transferred to Zeta-Probe GT blotting mem-
branes (BioRad), and hybridized according to the manufacturer’s
recommendations. A 0.8-kb fragment from the transgene con-
struct, spanning the DHJH complex, was used as a probe to detect
Dm transcripts. k transcripts were detected using a 0.4-kb frag-
ment comprising the 39 portion of the Ck gene, and a 0.9-kb
probe containing part of the mouse mb-1 gene (25; provided by
Dr. Michael Reth, Institute for Biology III, Freiburg, Germany)
was used to determine the amount of B cell–derived RNA in the
samples.
Western Blot Analysis. Proteins were prepared by lysing 3–10 3
106 cells from bone marrow, or from spleen, in 100 ml sample
buffer (135 mM Tris-HCl, pH 6.8, 2.5% SDS, 10% glycerol, 10%
2-mercaptoethanol, and bromophenolblue indicator [BFB]) and
applying the suspension to a 5–15% SDS-PAGE gradient gel.
Fractionated proteins were electroblotted onto Immobilon-P
transfer membranes (Millipore Corp., Bedford, MA) using a
Trans-Blot cell (BioRad). Immunodetection of the Dm chain was
carried out using a horseradish peroxidase–labeled anti-IgM anti-
body (Southern Biotechnology Associates, Birmingham, AL) and
an ECL Western blotting kit (Amersham Corp., Arlington
Heights, IL) according to the manufacturer’s protocol.
Flow Cytometry Analysis and Cell Sorting. Bone marrow cells
were flushed out of the femurs with HBSS. Spleen cells were ob-
tained by homogenization of the organ in the same medium.
Cells were collected by centrifugation, resuspended in FACS me-
dium (3% fetal calf serum and 0.1% sodium azide in PBS),
counted, and 106 cells/25 ml were incubated with antibodies.
The antibodies used were: biotin-coupled anti-B220 RA3.6.B2
(30), FITC-labeled anti-IgM (Southern Biotechnology Associ-
ates), FITC-labeled anti-CD43 (PharMingen, San Diego, CA),
biotin-coupled anti–heat stable antigen (HSA) (PharMingen), and
streptavidin PE–labeled anti–BP-1 (PharMingen). PE– and Cy-
chrome–conjugated streptavidin were obtained from PharMin-
gen. Stained cells were analyzed on a FACSCaliburÒ (Becton
Dickinson, Mountain View, CA). For cell sorting, bone marrow
cells were stained with the same reagents and separated on a
FACStar PlusÒ (Becton Dickinson).
Figure 2. Flow cytometric analysis of newborn
liver and bone marrow cells from Dm-endo trans-
genic mice, Dm-mb-1 transgenic mice, and litter-
mate controls. Cells were stained with anti-B220-PE
and anti-IgM-FITC and analyzed on FACScanÒ.
The lymphocyte population was gated according to
standard forward- and side-scatter values. The num-
bers above the framed areas represent the percent-
age of B2201IgM2 and B2201IgM1 cells out of the
total number of gated lymphocytes.
Table 1. Number of IgM1 B Cells and of Total Nucleated Cells
Transgenic
construct Founder TG/LM*
Newborn liver
n
3-wk-old spleen
n
Adult spleen
n
Nucleated cells
3 106
IgM1 cells
3 104
Nucleated cells
3 106
IgM1 cells
3 106
Nucleated cells
3 106
IgM1 cells
3 106
Dm-endo 11 TG 12.5 (6 3.9)† 3.5 (6 0.6) 3 18.2 (6 6.3) 2.9 (6 2.6) 4 37.0 (6 4.2) 18.2 (6 1.9) 2
LM 16.4 (6 2.4) 51.5 (6 9.8) 4 36.2 (6 6.2) 13.7 (6 4.1) 5 79.0 (6 19.8) 42.8 (6 7.1) 2
Dm–mb-1 26 TG 7.1 (6 1.4) 7.4 (6 2.2) 5 ND ND ND ND –
LM 8.2 (6 2.3) 22.3 (6 8.9) 5 ND ND ND ND –
*TG, transgenic; LM, littermates.
†Numbers given within parenthesis represent standard deviation.706 Regulation of B Lymphocyte Development
Results and Discussion
Dm Expression Leads to Arrest in VH to DHJH Rearrange-
ments. Five founder transgenic mouse lines were estab-
lished expressing Dm under the control of the endogenous
DH promoter, and four lines were established with Dm ex-
pression controlled by the mb-1 promoter (25–27; Fig. 1
A). Each of the founder mice were crossed to C57BL/6
mice and were analyzed for integration of the transgene by
genomic Southern blots using a probe hybridizing to the
Cm1 exon (Fig. 1 B). Transcription of transgenic Dm in
splenic and bone marrow cells from transgenic mice was
demonstrated by Northern blot analysis (Fig. 1 C). Western
blot analysis of cell lysates was used to confirm the expres-
sion of transgenic Dm protein. Thus, Dm protein was
readily detected in bone marrow cells and in spleen cells
from transgenic, but not from littermate mice (Fig. 1 D).
To directly test if the expression of Dm protein would af-
fect the VHDHJH rearrangement process, the relative
amount of complete VHDHJH and of incomplete DHJH rear-
rangements was estimated in B2201CD431 early B cell
progenitors using a semiquantitative PCR assay (28). As il-
lustrated in Fig. 1 E, the relative amount of complete VH-
DHJH rearrangements was found to be severely reduced in
the transgenic mice compared to littermate controls. In
contrast, DJH rearrangements were more abundant in the
transgenic mice. Together, these data provide evidence for
that expression of the Dm protein mediates inhibition of
VH to DJH rearrangements.
Partial B Cell Depletion in Dm Transgenic Mice. To study
the effect of the transgenically expressed Dm protein on the
B cell compartment, newborn liver, bone marrow, and
spleen cells from two transgenic lines were analyzed by
flow cytometry. Analysis of B lymphocytes from newborn
mice revealed an z3- and 15-fold reduction of IgM posi-
tive cells in the liver (Table 1, Fig. 2). In 3-wk-old mice, B
cell numbers were reduced about fourfold in transgenic
mice compared to littermate controls (Table 1). In adult
spleen, the number of total B cells was approximately two-
fold lower in the transgenic mice (Table 1), whereas the T
cells numbers were apparently unchanged (data not
shown). At all time points analyzed, no significant differ-
ence in the proportion of CD51 and CD52 B cells in the
peritoneum was observed, indicating that the generation of
B-1 cells and of conventional B cells were similarly affected
by the transgenic Dm expression (data not shown).
Impairment of B Cell Differentiation in Dm Transgenic Mice
Occurs at the Pro/Pre B Cell Stage. To identify the stage at
which the B cell development was affected by the trans-
genic expression of Dm, bone marrow cells from adult
mice were analyzed by flow cytometry. The number of
immature and mature B cells (B2201IgM1) was diminished
approximately two- to threefold in transgenic mice,
whereas the B2201IgM2 population, including most B cell
progenitors, was similar or only slightly reduced compared
to littermate controls (Fig. 2).
The stages of B cell differentiation have been subdivided
into fractions (A–F) on the basis of expression of the cell
surface markers B220, CD43, HSA, BP-1, and IgM (31).
Analysis of bone marrow cells using these markers revealed
that the B2201CD431 early progenitors were slightly in-
creased in transgenic mice, whereas B2201CD432 cells
were fourfold reduced compared to littermate controls
(Fig. 3). These results suggested that the observed block in
B cell development induced by Dm expression occurs be-
fore the transition of late pro–B cells to the pre–B cell
stage.
To further dissect at what point in early B cell differenti-
ation Dm expression exerts its effect, BP-1, CD43, and
HSA expression was used to subdivide B cell progenitor
cell populations (31). As shown in Fig. 4, the CD43intBP11
cell population (late pro–B cells) was slightly increased in
transgenic mice compared to littermate controls. However,
although the number of CD43intBP11 cells with low ex-
pression of HSA was almost twofold higher in the trans-
genic versus wild-type mice, the number of CD43intBP11
cells with high level expression of HSA was similar. Thus,
Figure 3. Flow cytometric analysis of bone marrow cells from 3-wk-old
Dm-endo transgenic mice, Dm–mb-1 transgenic mice, and littermate
controls. (A) FACSÒ profiles of cells stained with anti-CD43 and anti-
B220 and analyzed on FACScanÒ. The lymphocyte population was gated
according to standard forward- and side-scatter values. The numbers
above the framed areas represent the percentage of B2201CD432 and
B2201CD431 cells out of the total number of gated lymphocytes. (B)
Numbers of B2201CD432 and B2201CD431 cells per femur displayed as
histogram plots.707 Tornberg et al.
the partial block in B cell development induced in the Dm
transgenic mice occurs at the transition of the fraction C to
the fraction C9 in the nomenclature of Hardy et al. (31),
i.e., at the developmental stage where m chain expression
on the cell surface is required for further differentiation.
Our results provide support for the hypothesis that the
Dm pBCR can mediate a block in B cell development,
probably by inhibiting further VH to DHJH rearrangement
(32, 33) similar to the pBCR (10–13). This mechanism ap-
pears, however, to allow leakage of cells that can complete
VHDHJH rearrangement in the presence of Dm expression.
This is not surprising in view of the observed production of
endogenous rearrangements in transgenic mice expressing a
IgH chain (10–13). It is predicted from the proposed action
of Dm expression that most or all of these mature B cells
should contain only one complete VHDHJH rearrangement.
Experiments addressing this issue are presently ongoing.
Dm Induces Light Chain Rearrangements. In addition to
inhibiting VH to DHJH rearrangements, Dm expression has
been suggested to mediate induction of VL to JL rearrange-
ments (21, 32). If so, progenitor B cells of the Dm trans-
genic mice would be expected to rearrange the light chain
locus despite the arrest in B cell development and the pos-
sible impairment of VH to DHJH rearrangements. To test
this hypothesis, we analyzed the levels of expression of k
chain messenger RNA in bone marrow cells. The levels of
k transcripts were found to be similar in transgenic mice
compared to littermate controls (Fig. 5). Since in transgenic
mice there is a three- to four-fold reduction in the B cell
progenitors that normally produce L chain transcripts, these
results suggest that Dm expression induces VL to JL in pro-
genitors that normally would contain the light chain loci in
germline configuration. It appears, thus, that Dm can re-
place the complete mH chain in terms of mediating induc-
tion of VL to JL rearrangements.
We conclude from these results that the Dm pBCR can
mediate a block in B cell development, probably by inhib-
iting VH to DHJH rearrangements, as well as inducing VL to
JL rearrangements. In contrast, Dm cannot substitute for the
requirement of mH chain expression for pre–B cell transi-
tion. These observations are in agreement with previous
reports demonstrating that Dm counterselection is medi-
ated through the transmembrane domain of the membrane
Dm protein (33) and is dependent on the expression of Igb
(23) and Syk (22). It has been suggested that the inability of
Dm to mediate pre–B cell transition would be due to a fail-
ure to pair with L chains (24). This explanation seems un-
likely, however, because counterselection of the Dm pro-
tein-encoding RF2 appears to occur before the stage of L
chain expression (34). An alternative explanation may be
that the Dm pBCR and the pBCR generate qualitatively
different signals (12). Further analysis of the Dm transgenic
mice will be able to directly assess this possibility.
Figure 5. Northern blot anal-
ysis of total RNA from bone mar-
row and spleen cells hybridized
with a probe complementary to
the Ck. Blots from transgenic (tg)
mice and wild-type littermates
(lm) are shown. Lanes 1, 2, 5,
and 6: Dm-mb-1 line 26. Lanes
3, 4, 7, and 8: Dm-endo line 11.
The k transcript is indicated in
the figure. mb-1 was used as a
control for quantification.
Figure 4. Flow cytometric analysis of bone marrow cells from 3-wk-old
Dm-endo transgenic mice, Dm–mb-1 transgenic mice, and littermate
controls. (A) FACSÒ profiles of cells stained with anti-CD43, anti-BP-1,
and anti-HSA, and analyzed on FACScanÒ. The lymphocyte population
was gated according to standard forward and side-scatter values. Cells ex-
pressing BP-1 and intermediate levels of CD43 (indicated as a framed
population) were analyzed for HSA expression and are displayed as a sep-
arate histogram. (B) Numbers of CD431, BP-11, HSAhigh and CD431,
BP-11, HSAlow cells per femur are displayed as histogram plots.
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